Kangmei Pharma | 600518 - Market Capitalization

Stock Price
1.93
Daily Change
0.02 1.05%
Monthly
-1.53%
Yearly
-12.27%
Q1 Forecast
1.85

Kangmei Pharma reported CNY26.76B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 322M 180M Jun/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Genomma Lab Internacional MXN 17.87B 1.37B Feb/2026
Hypermarcas BRL 15.96B 1.74B Feb/2026
Ionis Pharmaceuticals USD 12.16B 652M Feb/2026
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Jiangsu Hengrui CNY 477.39B 133.64B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Moderna USD 16.5B 6.41B Feb/2026
Organon & Co USD 1.89B 29.17M Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Sh Fosun Pharma CNY 75.97B 14.49B Sep/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Wuxi Apptec CNY 330.55B 129.92B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025